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Background: Through several observational and mechanistic studies, microbial infection is known to promote
cardiovascular disease. Direct infection of the vessel wall, along with the cardiovascular risk factors, is hypothesized
to play a key role in the atherogenesis by promoting an inflammatory response leading to endothelial dysfunction
and generating a proatherogenic and prothrombotic environment ultimately leading to clinical manifestations of
cardiovascular disease, e.g., acute myocardial infarction or stroke. There are many reports of microbial DNA isolation
and even a few studies of viable microbes isolated from human atherosclerotic vessels. However, high-resolution
investigation of microbial infectious agents from human vessels that may contribute to atherosclerosis is very limited. In
spite of the progress in recent sequencing technologies, analyzing host-associated metagenomes remain a challenge.
Results: To investigate microbiome diversity within human atherosclerotic tissue samples, we employed high-throughput
metagenomic analysis on: (1) atherosclerotic plaques obtained from a group of patients who underwent endarterectomy
due to recent transient cerebral ischemia or stroke. (2) Presumed stabile atherosclerotic plaques obtained from autopsy
from a control group of patients who all died from causes not related to cardiovascular disease. Our data provides
evidence that suggest a wide range of microbial agents in atherosclerotic plaques, and an intriguing new observation
that shows these microbiota displayed differences between symptomatic and asymptomatic plaques as judged from the
taxonomic profiles in these two groups of patients. Additionally, functional annotations reveal significant differences in
basic metabolic and disease pathway signatures between these groups.
Conclusions: We demonstrate the feasibility of novel high-resolution techniques aimed at identification and
characterization of microbial genomes in human atherosclerotic tissue samples. Our analysis suggests that distinct groups
of microbial agents might play different roles during the development of atherosclerotic plaques. These findings may
serve as a reference point for future studies in this area of research.Background
Cardiovascular disease is the leading cause of death
worldwide, and atherosclerosis, its primary cause, is a
chronic inflammatory disease traditionally associated with
risk factors such as male sex, age, smoking, hypertension,
hyperlipidemia, obesity, and diabetes. However, elevated
circulating levels of inflammatory markers, e.g., high-
sensitivity C-reactive proteins are also risk markers for
atherosclerotic disease and increasing evidence indicates* Correspondence: suparna.mitra@ifr.ac.uk; mgivskov@sund.ku.dk
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(http://creativecommons.org/publicdomain/zethat infections and chronic inflammatory diseases, e.g.,
rheumatoid arthritis, are also linked with increased risk of
atherosclerosis [1–3]. Indeed, direct microbial infection in
the vessel wall can promote inflammatory responses and
generation of a proatherogenic and prothrombotic envir-
onment, while secreted bacterial products, e.g., lipopoly-
saccharide and heat shock proteins, can also indirectly
induce autoimmunity and other immunoinflammatory
mechanisms that may contribute to the atherosclerotic
process [1, 2].
Specifically, a number of infectious agents have
been suggested to promote atherosclerosis, e.g., Chla-
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Mitra et al. Microbiome  (2015) 3:38 Page 2 of 14virus, Pseudomonas aeruginosa, and Cytomegalovirus and
oral bacteria such as Porphyromonas gingivalis, Aggregati-
bacter actinomycetemcomitans, and Prevotella intermedia
involved in marginal periodontitis, have been associated
with atherosclerotic disease, e.g., acute myocardial infarc-
tion [4, 5]. Indeed, previous studies have identified DNA
from a broad variety of bacteria in atherosclerotic plaques
[6]. Bacterial 16S rDNA signatures from environmental
microorganisms and several nosocomial pathogens and vi-
ruses were recently found in atherosclerotic lesions of pa-
tients with coronary heart disease [7, 8]. As compared to
asymptomatic stable plaques, culprit lesions associated
with atherosclerotic disease manifestations, e.g., myocar-
dial infarction or stroke, are associated with increased in-
flammation and thrombosis, but differences in bacterial
profiles of unstable vs. stable atherosclerotic plaques have
not been investigated.
Even though the above pathogens have been reported
to be present in plaques, there is a lack of published
high-resolution investigations of dynamic composition
of microbial infectious agents that may be associated
with development of atherosclerosis. The traditional ap-
proach for identifying microbes from target sites such as
culturing and 16S rRNA PCR sequencing are quite lim-
ited for characterization of numerous infectious agents
[4, 6]. Recent progress in deep sequencing technology has
provided another potential approach for high throughput
and comparative analysis of the atherosclerosis-associated
microbial agents. Also, metagenomics has the potential to
characterize microbial communities in various sites of hu-
man body and give a deeper understanding of their impact
on human physiology and diseases [9]. However, many
challenges still remain in applying metagenomics analysis
of atherosclerotic plaque samples. For example, athero-
sclerotic plaques contain large amounts of human gen-
ome DNA which can reduce the microbial genome
DNA reads during sequencing. Similar considerations
apply for analyses of target tissue samples from other
host inflammation-associated diseases like periodontal
diseases, non-healing ulcers, or traumatic wounds.
Here, with the use of two different types of athero-
sclerotic tissue samples, symptomatic atherosclerotic
plaques from patients with symptomatic atherosclerotic
disease and asymptomatic atherosclerotic plaques from
patients that have atherosclerotic tissues died from other
causes than atherosclerosis, we performed a comparative
metagenomic analysis of the contribution of microbial
community to the development of atherosclerotic dis-
ease. The atherosclerotic microbial communities were
analyzed by applying deep sequencing and a multistage
approach using different methods to reduce human gen-
omic reads and hereby achieve improved understanding
of the bacterial communities potentially involved in hu-
man disease. We identified bacterial families of potentialimportance for eliciting the transition from asymptom-
atic to symptomatic atherosclerotic disease.Results
Sequencing and data processing
All 22 arterial plaque samples resulted in 2,610,268,774
reads. After mapping these reads against Hg19 using
bowtie 2, the average amount of non-Hg19 reads is
884,727,044 (average 33.89 % per sample, Table 1). These
non-Hg19 reads were aligned on NCBI-nr and imported
in MEGAN using parameters as detailed in the
“Methods” section.Taxonomic annotation
For all non-Hg19 annotated reads, 2 to 16 % (mean
4.6 %) were assigned as bacteria in different samples.
The rest of reads were Eukaryota. Table 1 provides de-
tails of sequencing read statistics and assignments of
reads after different stages of data processing. Figure 1
depicts a hierarchical clustering result of family level
taxonomic comparison data for all 22 samples. Interest-
ingly, samples 238 and P0613 were mostly different, and
among the other samples, all unstable plaques clustered to-
gether, apart from all stable plaque controls that clustered
separately. Interestingly, the asymptomatic atherosclerotic
plaques have more abundance of host microbiome-
associated microbial families such as Porphyromonadaceae,
Bacteroidaceae, Micrococcaceae, and Streptococcaceae than
the symptomatic atherosclerotic plaques (Fig. 1). In con-
trast, the symptomatic atherosclerotic plaques have more
abundance of pathogenic microbial families such as Helico-
bacteraceae, Neisseriaceae, and sulfur-consuming families
such as sulfur-oxidizing symbionts and Thiotrichaceae
than the asymptomatic atherosclerotic plaques (Fig. 1).
Additional file 1: Figure S1 provides a multiple compari-
son tree view using taxonomic annotation of all 12 sam-
ples at “family” level of NCBI taxonomy. In this figure, the
samples from patients with symptomatic atherosclerosis
(unstable plaques) are displayed in white and the control
samples of stable lesions (are displayed in gray color).
Despite our efforts to clean up human gene sequences
from the samples, we found that some of the human-
like sequences remained detectable. This was probably
caused by the high level of variation in our samples
compared to the hg19 reference genome. Indeed, some
human sequences can cause false hits to species which
have similar sequence structure. Some of the species hits
that are likely to be of human origin were those for
Microbacterium laenivormans, Cyanothece, Coprobacil-
lus, and Aster Yellows Phytoplasma which were therefore
marked with black crosses in Additional file 1: Figure S1,
and we discarded these four species before clustering
(Fig. 1).












Cases Hiseq 2000 48 93,124,682 31,504,036 33.83 8,404,029 3,763,197 243,336 2.90 %
Hiseq 2000 49 101,840,018 53,068,718 52.11 12,405,108 6,772,304 436,463 3.52 %
Hiseq 2000 50 94,765,328 43,109,046 45.49 11,643,905 6,419,975 505,239 4.34 %
Hiseq 2000 51 112,426,390 50,653,838 45.06 10,711,699 4,899,567 216,511 2.02 %
Hiseq 2000 52 88,328,470 36,795,952 41.66 10,574,678 5,766,665 492,013 4.65 %
Hiseq 2000 53 124,000,764 41,858,084 33.76 10,057,354 4,676,002 243,775 2.42 %
Hiseq 2000 54 93,124,682 82,366,266 88.45 19,199,623 9,229,157 365,993 1.91 %
Hiseq 2000 237 141,334,092 58,853,792 41.64 6,946,473 3,854,397 249,369 3.59 %
Hiseq 2000 238 153,302,968 36,976,828 24.12 5,216,154 3,002,923 835,412 16.02 %
Hiseq 2000 239 154,652,444 48,177,200 31.15 5,643,923 3,045,461 222,363 3.94 %
Hiseq 2000 240 101,591,496 46,000,276 45.28 5,166,877 2,640,033 110,186 2.13 %
Hiseq 2000 241 99,927,824 42,032,952 42.06 4,607,355 2,471,259 153,425 3.33 %
Hiseq 2000 242 82,850,664 46,721,284 56.39 5,002,916 2,716,756 135,617 2.71 %
Hiseq 2000 243 104,094,892 52,853,464 50.77 5,726,930 3,095,542 193,819 3.38 %
Hiseq 2500 977 (P0613) 111,699,176 13,191,406 11.81 2,344,220 955,602 74,646 3.18 %
Miseq V1 P0613 repeat 7,184,184 980,004 13.64 759,262 228,262 31,889 4.20 %
977 + APD1 118,883,360 14,171,410 11.92 3,103,482 1,183,864 106,535 3.43 %
Controls Hiseq 2000 55 105,779,932 29,019,712 27.43 8,911,853 4,040,359 293,160 3.29 %
Hiseq 2000 56 128,471,814 10,767,822 8.38 4,680,735 1,922,688 204,397 4.37 %
Hiseq 2000 232 127,173,774 25,793,632 20.72 3,267,969 1,726,714 164,711 5.04 %
Hiseq 2000 233 166,547,592 29,282,304 17.58 4,559,468 2,634,338 649,226 14.24 %
Hiseq 2000 234 114,673,124 37,683,568 32.86 4,550,457 2,477,740 193,659 4.26 %
Hiseq 2000 235 151,195,284 34,767,160 22.99 4,633,661 2,550,975 231,926 5.01 %
Hiseq 2000 236 152,179,180 32,269,700 21.21 4,254,572 2,319,403 204,778 4.81 %
Total 2,610,268,774 685,143,146 26.25 4.60 %
Details of sample information, sequencing read statistics, and assignments of reads after different stages of data processing
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curve (Fig. 2), it is apparent that 2 (sample 233 and 238)
of the 22 samples had much higher sequencing depth
than the other samples (Table 3). Additionally, the PCoA
plot and UPGMA tree of the taxonomic profile (Fig. 3)
showed clustering among the unstable plaques and
among the control samples, respectively, using species
level data. Only three samples (233, 238, and P0613)
remained separated, and it appears that the high diver-
sity caused by the sequencing depth is a major contribu-
tor for separation of samples 233 and 238. For P0613,
the species profile appeared very different from all other
samples (Fig. 1). We therefore omitted these three samples
from the merged samples. Figure 4 depicts a multiple com-
parison tree view at “family” level of NCBI taxonomy using
the normalized total biome for the merged samples. The
taxonomic profile in this tree view was consistent with re-
sults of comparisons between all samples (Additional file 1:Figure S1). Figure 5 shows the 25 most abundant species
in the total biome for merged samples (excluding 4 biased
species, as mentioned earlier). Among the most prevalent
species in case samples were Lactobacillus rhamnosus
MTCC 5462, Neisseria polysaccharea ATCC 43768, H.
pylori Hp P-4, and Acidovorax spp. CF316.
Functional analyses and comparison of total biome
MEGAN’s functional analyses using SEED and KEGG
classification are shown in Additional file 2: Figure S2 and
Additional file 3: Figure S3 at the second level of the SEED
and KEGG hierarchy. From both figures, it is apparent
that all of the involved metabolisms were driven mostly by
samples 233 (violet) and 238 (red), and this might also be
caused by higher sequencing depth for this two samples as
described in the “Taxonomic annotation” section.
Additionally, from functional annotation of the total
biome for the two groups of samples (unstable vs. stable
Mitra et al. Microbiome  (2015) 3:38 Page 4 of 14plaques, excluding samples 233, 238, and P0613), we
noticed significant differences in basic metabolic and
disease pathway signatures. Based on normalized com-
parisons of total bacterial reads in two groups, reads
assigned to functional metabolism were much lower for
unstable plaques (white) compared to stable lesions
(gray). Figure 6a depicts the difference of KEGG ortholo-
gies (level 2), and Fig. 6b provides comparison of the top
50 SEED-level 2 subsystems for the two sample groups.
These functional annotations suggested involvement
of basic metabolic and disease pathways such as those
related to “carbohydrate”, “amino acid”, and “energy”
metabolisms. Moreover, entities perceived to be of pre-
dominant relevance to atherosclerosis, i.e., “cardiovascular
diseases”, “circulatory system”, “immune system”, and “cell
growth and death”, and to “infectious diseases”, respect-
ively, are also found.
To characterize the growth physiology of potential
bacterial species in the plaque, we performed FISH ana-
lysis to visualize the distribution of two selected species
from the most abundant bacterial species, Acidovorax
spp. and H. pylori, within multiple plaque samples (see
the “Methods” section). Table 3 provides the details of
the probes. Figure 7 shows representative images of
plaque samples after applying the Acidovorax spp.-specific
probe, H. pylori-specific probe, as well as two negative con-
trol probes (Candidate division TM7 and Paracoccus spp.)
on plaque material from several different patients. We ob-
served morphologically distinct clusters of Acidovorax spp.
and H. pylori cells surrounded by atherosclerotic tissue
material (Fig. 7a, b). In contrast, the two negative control
probes produced almost no signal after being applied to
plaque samples (Fig. 7c, d).Discussion
Atherosclerosis is a chronic inflammatory disease that is
generally perceived to be driven by classical risk factors
(smoking, diabetes, hypertension, etc.). However, evi-
dence accumulated in the last 25 years suggests that in-
fection can also play an important contributory role by
direct and indirect mechanisms [1–3]. In the present
study, we used deep sequencing and metagenomic ana-
lysis to provide a high-resolution investigation of micro-
bial species in atherosclerotic plaques from stable
asymptomatic lesions and unstable lesions removed at
surgery. We provided details of a multi-step protocol to
reduce human DNA reads in order to obtain a compre-
hensive picture of the microbial community present in
the diseased arterial wall. A similar protocol can be ap-
plied to any host-associated metagenomics study.
To date, a wide range of infectious agents have been
linked to atherosclerosis, and while H. pylori, Cyto-
megalovirus, Hepatitis C virus, and other species havealso been implicated, the current weight of evidence has
arguably favored the involvement of C. pneumoniae and
periodontal organisms such as P. gingivalis [2–4]. How-
ever, these works were based on final point sampling of
the symptomatic atherosclerotic plaques samples. The
lack of asymptomatic atherosclerotic plaques samples
limits our understanding of the roles of microbial agents
for contributing to the development of the atheroscler-
otic diseases. Also, recent research has suggested that
the contribution from an aggregate “infectious” burden
induced by a large number of pathogens is much more
important for atherosclerosis development than any sin-
gle organism [3, 10, 11].
Our work provides the first comparative metagenomic
analysis of atherosclerotic plagues from the symptom-
atic atherosclerotic disease patients and asymptomatic
atherosclerotic samples from a control group of patients
that have atherosclerotic tissues died from other causes
than atherosclerosis. The asymptomatic atherosclerotic
plaques have more abundance of host microbiome-
associated microbial families such as Porphyromonada-
ceae, Bacteroidaceae, Micrococcaceae, and Streptococca-
ceae [12] than the symptomatic atherosclerotic plaques
(Fig. 1). This result suggests that these host microbiome-
associated microbial families are one of the first colonizers
of the arteries. These early colonizers might support
the growth of sulfur-consuming families such as
sulfur-oxidizing symbionts and Thiotrichaceae [13] and
pathogens such as Helicobacteraceae and Neisseriaceae,
which were found to be abundant in the symptomatic ath-
erosclerotic plaques (Fig. 1). It is well known that homo-
cysteine, an intermediate in sulfur-containing amino acid
methionine metabolism, is highly related to the vascular
disease, and arteriosclerosis patients have elevated
levels of homocysteine in their blood [14]. The elevated
levels of homocysteine might facilitate the thrive of
sulfur-consuming families. The presence of pathogens
might enhance the degeneration of elastic fibers and
fragmentation of the internal elastic membrane by their
elastase activity. Further study is required to investigate
the potential interactions of commensal and pathogen pop-
ulations during the transition from asymptomatic athero-
sclerotic plaques to symptomatic atherosclerotic plaques.
Some of the infectious agents that are most preva-
lent in our symptomatic atherosclerotic samples, e.g.,
Acinetobacter, Acidovorax, and N. polysaccharea have
not been reported previously. FISH observation vali-
dated the presence of biofilm-like structures of these
pathogens in the symptomatic atherosclerotic plague
samples (Fig. 7). In addition, the presence of multiple
pathogens in atherosclerotic plaques and their poten-
tial organization in biofilms may be part of the ex-
planation underlying other pertinent findings in this
area of research, e.g., absence of effect of antibiotic
Fig. 1 Taxonomic comparison of all DNA samples. Hierarchical clustering result of “family” level taxonomic comparisons of data from unstable
atherosclerotic plaques from 15 patients with symptomatic atherosclerotic disease (unstable plaques) and stable plaques from a control group
of 7 patients that died from other causes than atherosclerosis (controls). Red indicates down-regulation, green indicates up-regulation, and black indicates
no change in read abundance level comparing to all samples. Hierarchical clustering was computed with average linkage, whereas Pearson correlation
was used for clustering the families (rows) and Spearman correlation was used for clustering the datasets (columns), respectively
Mitra et al. Microbiome  (2015) 3:38 Page 5 of 14
Mitra et al. Microbiome  (2015) 3:38 Page 6 of 14treatment on clinical endpoints in high-risk patients
with coronary artery disease, and an apparent correl-
ation between oral, gut, and atherosclerotic plaque
microbiotas [5, 15, 16]. Indeed, a very recent study
suggested the presence of P. aeruginosa biofilms
within the plaque in patients with advanced athero-
sclerotic disease [5]. In our study, however, we found
only a very low number of Pseudomonas reads in four
symptomatic atherosclerotic plague samples (average
0.08 % reads of all assigned bacteria) out of 15 un-
stable plaque samples and in one asymptomatic ath-
erosclerotic plague samples sample (0.048 % reads)
among seven plaques, respectively. These differences in
observation of Pseudomonas abundance between their
study and our study might due to the fact that we used
deep shotgun sequencing approach, which might have
helped to obtain greater picture of the microbial commu-
nity. More studies are clearly needed to determine the pu-
tative identity, organization, and role of bacteria detected
in atherosclerotic plaques.Fig. 2 Rarefaction. Rarefaction plot using annotated species profile for all 22 (
the number of nodes that would be present if based on 10, 20, and up to 90The functional analyses reported in the current study
represent an innovative method to investigate mecha-
nisms of potential relevance to atherosclerosis. Interest-
ingly, these results show basic (carbohydrate, amino
acid, and energy metabolism) pathways, whereas poten-
tial pathways for causing cardiovascular diseases and
infectious diseases are also identified. However, these re-
sults should be viewed as preliminary and hypothesis-
generating, and more research is required to provide
more insights into atherosclerosis pathobiology. In
addition to this context, it is worth to mention that cur-
rently, we are working on the next phase of this project
using transcriptomics. RNA will help us in better under-
standing of activity of these metabolisms.
Important limitations to this study include lack of true
negative controls, i.e., arterial samples without athero-
sclerosis, and absence of histologic examinations to es-
tablish signs of plaque (in)stability. Although we found
an abundance of microbial genetic material, we cannot
conclude that these agents were viable within theunstable and stable) atherosclerotic plaque samples. These curves show
% of the reads
Fig. 3 Multiple comparison clustering. Clustering of the 22 atherosclerotic samples using a principal coordinate analyses (PCoA) and b unweighted
pair group method with arithmetic mean (UPGMA) tree. The 15 unstable atherosclerotic plaque samples (cases) are displayed in white and the 7 stable
plaque samples (controls) in gray
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Fig. 4 Taxonomic comparison of all DNA samples. Comparative tree view of merged samples (excluding samples 233, 238, and P0613) from unstable
atherosclerotic plaques (white) and control group of stable plaques (gray) at “family” level of NCBI taxonomy. The scale shows the log value of reads
assigned directly to a particular node. Some of the species hits that are likely to be of human origin are marked with black crosses
Mitra et al. Microbiome  (2015) 3:38 Page 8 of 14atheromatous plaque. For example, bacterial DNA found
within the sampled atheroma could represent DNA frag-
ments from bacteria engulfed and killed elsewhere in the
body by phagocytic cells that subsequently entered the
atherosclerotic vessel segment. Study limitations also in-
clude risk of microbial contamination of tissue samples.
Conclusions
This paper describes a novel approach to apply high-
throughput sequencing and whole-genome shotgun
metagenomics on plaque tissue samples to investigatemicrobiome diversity of the plaque obtained from pa-
tients with a thrombotic event and controls with non-
symptomatic plaques. Our data provides evidence that
suggest a wide range of microbial agents in atheroscler-
otic plaques and an intriguing new observation that
shows these microbiota displayed differences between
symptomatic and asymptomatic plaques as judged from
the taxonomic profiles in these two groups of patients.
Additionally, functional annotations reveal significant
differences in basic metabolic and disease pathway sig-
natures between these groups.
Fig. 5 Top 25 abundant species. Top 25 abundant species for all (unstable and stable) atherosclerotic plaque samples (excluding samples 233,
238 and P0613) are displayed in a bar chart
Mitra et al. Microbiome  (2015) 3:38 Page 9 of 14Methods
Patients and samples
For this study, we used atherosclerotic tissue samples
from a group of 15 patients that underwent elective
carotid endarterectomy following repeated transient is-
chemic attacks or minor strokes (samples from symp-
tomatic atherosclerotic plaques as cases (Table 1). Our
methods and experimental manuals were approved by
The National Committee on Health Research Ethics
(Danish) and was granted by the Ethical Committee of
the region of Copenhagen (H-3-2011-013). Further, we
have asymptomatic atherosclerotic plaques from seven
persons who died from causes not related to athero-
sclerotic disease (samples from stable plaques as con-
trols; Table 1) that originated from the tissue bank at
the Department of Forensic Medicine (Approval No.
1501230). The approvals do not allow us to collect
and use patient/person data for the analysis. Conse-
quently, after collection, all 22 samples were treated in
a blinded fashion during lab process, sequencing, and
data analyses.Sample collection and DNA sequencing
Appropriate material from diseased arteries taken at
sites of macroscopic atherothrombotic plaque was surgi-
cally dissected. Cross-sectional pieces of tissue 3–5-mm
thick were prepared and immediately stored at −80 °C.
DNA was extracted using QIAGEN’s DNeasy Blood &
Tissue kit, following the “Purification of Total DNA from
Animal Tissues (Spin-Column)” protocol. Briefly, tissue
was cut into tiny pieces of no more than 25 mg on a clean
Petri dish on dry ice and then homogenized in ATL buffer
with a 5-mm stainless steel bead (QIAGEN) on a Tissuely-
ser at 50 Hz for 2 min or until tissue was completely ho-
mogenized. After homogenization, proteinase K was
added and the sample was incubated at 56 °C until it was
completely lysed. The remaining steps of the protocol
were performed according to QIAGEN’s recommenda-
tion. DNA was eluted with 100 μL of buffer AE.
Prior to library preparation, the quality of the DNA
samples was assessed on a Bioanalyzer 2100, using a DNA
12000 Chip (Agilent). Sample quantitation was performed
using Quant-iT™ PicoGreen ® dsDNA Reagent.
Fig. 6 Functional comparison of total biome. Differences between total biome for unstable atherosclerotic plaque samples (white) and stable plaque
samples (blue) are displayed with comparative bar charts. a depicts the difference of KEGG orthologies (level 2) and b provides comparison of the two
groups with the top 50 SEED-level 2 subsystems
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prepared by following Illumina’s TruSeq DNA Sample
Preparation protocol. The samples were sheared on a
Covaris S220 to ~500 bp, following the manufacturer’s
recommendation. Size selection was performed on a
Sage Science Pippin Prep instrument using a 1.5 % EtBr
agarose cassette and selecting for a tight peak around
620 bp. Each library was uniquely tagged with one ofIllumina’s TruSeq LT DNA barcodes to allow library
pooling for sequencing.
Library quantitation was performed using Invitrogen’s
PicoGreen assay and the average library size was deter-
mined by running the libraries on a Bioanalyzer DNA
7500 chip (Agilent). Library concentrations were nor-
malized to 4 nM and validated by qPCR on a StepOne
Plus real-time thermocycler (Applied Biosystems), using
Fig. 7 FISH images of Acidovorax spp. and H. pylori in atherosclerotic plaque samples. Representative results of plaque samples after applying the
Acidovorax spp.-specific probe (a), H. pylori-specific probe (b), as well as two negative control probes, i.e., Candidate division TM7 (c), and Paracoccus spp.
(d), on atherosclerotic plaque material from several different patients. We observed morphogically distinct clusters of Acidovorax spp. and H. pylori cells
surrounded by atherosclerotic tissue material
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col, and Illumina’s PhiX control library as standard. Li-
braries were then pooled and sequenced in two lanes of
an Illumina HiSeq2000 sequencing run at a read length
of 101 bp paired-end. Table 1 provides details of sequen-
cing batch info. Library 977 (sample P0613) was first se-
quenced on a MiSeq V1 run, but due to the low number
of bacterial reads obtained, this sample was later also in-
cluded in a HiSeq2500 rapid sequencing run at a read
length of 101 bp paired-end to achieve a comparable
number of bacterial reads. We subsequently merged the
reads from both sequencing run for this sample and
treated these as one sample during data processing and
comparisons.Data processing
As arterial plaque samples represent a host-associated
metagenome, we mapped these reads against humanreference genome (hg19) using bowtie 2-2.0.0 [17] with
“very-sensitive” parameters to filter all human-like se-
quences from our samples. All unmapped reads (non-
hg19) were extracted and aligned against non-redundant
(nr) protein database (version 30.07.2012) [18] using
BLASTX (ncbi-blast-2.2.25+; Max e-value 10e-3) [19].
After performing the BLASTX alignment, all output files
of paired read sequences were imported and analyzed
using the paired-end protocol of MEGAN5 [20].
Taxonomic annotation
For processing the BLAST files by MEGAN5, we used
parameter settings of “Min Score = 50”, “Top Percent =
10”, “Min Support = 25,” and “Minimum sequence com-
plexity threshold = 0.44”. Some reads which did not have
any match to the respective database were placed under
a “No hit” node, and some reads that were originally
assigned to a taxon that did not meet our selected
threshold criterion were pushed back using the lowest
Table 2 Diversity indices




232 20 2.108 0.8319
233 129 1.753 0.575
234 49 2.816 0.9055
235 33 2.516 0.8869
236 18 1.942 0.8138
237 22 2.081 0.8451
238 361 3.524 0.918
239 15 1.941 0.8313
240 35 1.956 0.7783
241 28 2.306 0.863
242 14 1.898 0.8247
243 14 1.904 0.8263
48 16 1.516 0.6573
49 18 1.882 0.8169
50 18 1.718 0.7557
51 18 1.918 0.8018
52 32 1.995 0.7598
53 17 1.749 0.7501
54 12 1.541 0.7132
55 63 2.741 0.8437
56 20 1.205 0.4422
P0613_pooled 37 1.004 0.3896
Shannon-Wiener-diversity index (H) and Simpson’s diversity index (D) are reported
for each sample
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where the threshold was met. After importing datasets
in MEGAN, we obtained MEGAN-own “rma files” for
each data mapped onto NCBI taxonomy based on our
selected threshold. Further, only reads annotated as bac-
terial reads were extracted in new documents for each of
the 22 samples and used for later analyses.
Multiple metagenome comparison
All “rma files” were normalized to the smallest data set
size without the not-assigned reads to allow inter-
comparison of taxonomic abundances and to obtain
comparative tree view for all samples. Additionally,
“family” level taxonomic profile was used for hierarchical
clustering with average linkage where PearsonTable 3 Fluorescence in situ hybridization (FISH) probe information
No. Probe name Sequence
1 Target ACI208 [Cyanine5] CGCGCAA
2 Positive control ClaR2 [Cyanine5] CGGGGTC
3 Negative control PAR651 [cy5] ACC TCT CTC G
4 Negative control TM7305 [cy5] GTC CCA GTC Tcorrelation was used for clustering the families (rows)
and Spearman correlation was used for clustering the
datasets (columns) (Fig. 1). All computations were per-
formed using R 3.0.2 [21]. Also, we performed principal
coordinates analysis (PCoA) and unweighted pair group
method with arithmetic mean (UPGMA) hierarchical
clustering to compare taxonomic profiles of the samples
at “species” level of NCBI taxonomy using MEGAN5
(Fig. 3).
Rarefaction and diversity indices
We computed rarefaction curves from the normalized
profile of 22 samples using the bacterial reads, showing
the number of nodes that would be present in the ana-
lysis if based from 10 to 90 % of the reads. Further,
“Shannon” and “Simpson” diversity indices were calcu-
lated for all samples (Table 2).
Comparison of total biome: cases vs. controls
In addition to the above analyses, we merged the sam-
ples from the two patient groups, i.e., 15 symptomatic
atherosclerosis patient samples (cases, Table 1) and the
asymptomatic atherosclerotic samples from seven per-
sons who died from causes not related to atherosclerotic
disease (control, Table 1), to obtain a profile for the
merged datasets in agreement with the view that up to
the point of plaque instability, atherosclerosis pathogen-
esis is similar in symptomatic (unstable), and asymptom-
atic (stable) lesions. Only three samples (233, 238, and
P0613) were not included in the merged samples (see
the “Results” section).
Functional annotation
Additionally, a functional analysis was performed on all
samples using the SEED classification [22], based on the
given BLASTX alignment and for only bacterial reads,
using MEGAN5 as previously described [23]. In this
classification scheme, genes are assigned to functional
roles and genes with different functional roles are
grouped into subsystems. The SEED classification can be
represented as a rooted tree in which internal nodes rep-
resent different subsystems and where leaves represent
functional roles.
To obtain a tentative pathway analysis, we performed an
analysis based on Kyoto Encyclopedia for Genes and Ge-
nomes (KEGG) [24], where bacterial reads were mappedTarget
GGCCTTGC Acidovorax
TCTCCGTCTT Clarithromycin-resistant Helicobacter pylori 23S rRNA
AA CTC CAG Genus Paracoccus
GG CTG ATC Subdivision 1 of candidate division TM7
Mitra et al. Microbiome  (2015) 3:38 Page 13 of 14onto KEGG orthologous groups using MEGAN5. For
such analysis, the MEGAN program matched each read to
a KEGG orthology (KO) accession number, using the best
hit to a reference sequence for which a KO accession
number is known. The program reported the number of
hits to each KEGG pathway. For such functional annota-
tion using both SEED and KEGG, we first extracted all the
reads that were mapped to bacteria in taxonomic annota-
tions for all the datasets. Subsequently, we only processed
these reads to obtain SEED and KEGG classifications to
investigate metabolic or disease pathways of potential rele-
vance to atherosclerosis
Fluorescence in situ hybridization
Tissue samples were fixed with formalin and imbedded
in paraffin. Samples were de-paraffinized with xylene,
dehydrated, and washed. Oligonucleotide probes ACI208
(Acidovorax spp.), ClaR2 (H. pylori), and two negative
control probes TM7305 (Candidate division TM7),
PAR651 (Paracoccus spp.) (Sigma-Aldrich) were syn-
thesized and labeled with Cy5 (Table 3). Fluorescence
in situ hybridization (FISH) was performed according
to a previously reported authoritative protocol [25].
Hybridization buffer was transferred onto the samples
and followed by addition of individual gene probes
(working solution 50 ng/uL). After applying FISH probes
onto the tissue samples, slides were incubated in hu-
midified environment at 46 °C for 3 h to hybridize the
probe into target DNA. Different compositions of wash-
ing buffer were prepared corresponding to individual
formamide concentrations. Then, slides were washed
with preheated washing buffer at 48 °C (water bath) for
20 min, followed by snap dip in cold H2O and air-dried.
Signals for each probe were observed under LSM 780
confocal laser scanning microscope (CLSM) (Carl Zeiss,
Germany) equipped with GASP array detector and two
PMT detectors for fluorescence signal detections and
combination with T-PMT detector for transmitted im-
ages using Plan-Apochromat 40×/1.3NA oil objectives.
Auto-fluorescence signals were checked using CLSM to
avoid the biomass auto-fluorescence and determined the
specific emission spectrum of each FISH probes.
Data deposition
The sequence data obtained in this study have been depos-
ited in the NCBI database under BioProject/BioSamples
with accession number SRP040611.
Additional files
Additional file 1: Figure S1. Taxonomic comparison of all DNA samples.
Comparative analysis tree view for unstable plaque samples from seven
patients with symptomatic atherosclerotic disease (cases, white) and five
stable plaques from a control group (controls, gray) at “family” level of NCBItaxonomy. The scale shows the log value of reads assigned directly to a
particular node. Some of the family hits that are likely to be of human origin
are marked with black crosses. (EPS 923 kb)
Additional file 2: Figure S2. Functional annotation using SEED
subsystems. Multiple comparison tree view showing functional analyses
using level 2 of SEED subsystems. The scale shows the log value of reads
assigned directly to any particular subsystem. (EPS 1155 kb)
Additional file 3: Figure S3. Functional annotation using KEGG
orthologies. Multiple comparison tree view showing functional analyses
using level 2 of KEGG orthologies. The scale shows the log value of reads
assigned directly to any particular subsystem. (EPS 487 kb)
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